Synergistic photoinduction of ferroptosis and apoptosis by a mitochondria-targeted iridium complex for bladder cancer therapy DOI Creative Commons

J Zheng,

Aijing Zhang, Qinglong Du

и другие.

Journal of Colloid and Interface Science, Год журнала: 2024, Номер 683, С. 420 - 431

Опубликована: Дек. 12, 2024

Bladder cancer (BC) is one of the most common malignant tumors urinary system, and has a high recurrence rate treatment resistance. Recent results indicate that mitochondrial metabolism influences therapeutic outcomes BC. Mitochondria-targeted photosensitizer (PS) promising anticancer approach may overcome limitations conventional BC treatments. Herein, two mitochondria-targeted iridium(III) PSs, Ir-Mito1 Ir-Mito2, have been designed for treatment. Mechanically, Ir-Mito2 induced decrease in membrane potential via white light activation, further triggering reduction B-cell lymphoma 2 protein (Bcl-2)/Bcl-associated X (Bax) ratio increment cleaved caspase3. Meanwhile, glutathione, deactivation glutathione peroxidase 4 (GPX4), increase acyl-CoA synthetase long chain family member (ACSL4), accumulation lipid peroxide resulted synergistically activating ferroptosis apoptosis. The demonstrated exhibited excellent antitumor efficacy with superior biosafety vivo. This work on light-activated mitochondrial-targeted PS provides an innovative platform

Язык: Английский

Stacking machine learning models for predicting photophysical properties of iridium complexes DOI

Ding Peng,

Lin Liu,

Bin‐Bin Xie

и другие.

Journal of Photochemistry and Photobiology A Chemistry, Год журнала: 2025, Номер unknown, С. 116374 - 116374

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Gallium‐Magnesium Layered Double Hydroxide for Elevated Tumor Immunotherapy Through Multi‐Network Synergistic Regulation DOI
Jia Tan, Binbin Ding, Hao Chen

и другие.

Advanced Materials, Год журнала: 2025, Номер unknown

Опубликована: Апрель 7, 2025

Abstract Immunotherapeutic efficacy is often limited by poor immunogenicity, immunosuppressive tumor microenvironment (TME), and cytoprotective mechanisms, leading to low immune activation. To this end, here, L‐amino acid oxidase (LAAO) loaded gallium‐magnesium layered double hydroxide (MG‐LAAO) prepared for significantly enhanced immunotherapy through multi‐network synergistic regulation. First, MG‐LAAO induces cell pyroptosis initiating caspase‐1/GSDMD caspase‐3/GSDME pathways, further triggering immunogenic death (ICD). Then the released Ga 3+ mitochondrial iron overload, resulting in ferroptosis. In addition, also hinders autophagy of cells, reshapes (TME) neutralizing H + inhibiting lactic accumulation, thus destroying mechanism avoiding escape. Furthermore, synergy activates cGAS‐STING signaling pathway, generating powerful antitumor immunotherapy. This work highlights critical role synergies between block, pyroptosis, ferroptosis, ICD immunotherapy, demonstrating important effectively overcoming TME enhancing immunogenicity. particular, gallium‐induced revealed first time, providing theoretical support design new materials future.

Язык: Английский

Процитировано

0

Designing novel tridentate iridium(III) complexes comprising functionalized benzothiazole ligands to improve anticancer activity by targeting mitochondria DOI
Qin Zhou, Xiaobin Zhang,

An-Li Liu

и другие.

Bioorganic Chemistry, Год журнала: 2025, Номер unknown, С. 108507 - 108507

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Molecular engineering strategies for fabricating type-I mitochondria-targeted aggregation-induced emission photosensitizers for apoptosis-ferroptosis synergistically boosting photodynamic therapy DOI
Shihua Wang, Yiting Qiu, Lichao Yu

и другие.

Journal of Colloid and Interface Science, Год журнала: 2025, Номер 694, С. 137680 - 137680

Опубликована: Апрель 23, 2025

Язык: Английский

Процитировано

0

Pyrazolo[1,5-a]pyrimidine-Based Type-I Photosensitizer as an Efficient Pyroptosis Inducer for Tumor Ablation DOI
Shuo Zhang,

Jingru Qiu,

Hao Zhang

и другие.

Journal of Medicinal Chemistry, Год журнала: 2025, Номер unknown

Опубликована: Май 4, 2025

Pyroptosis is a proinflammatory and lytic programmed cell death form, which can promote cytotoxic T lymphocyte (CTL) maturation tumor infiltration through the release of damage-associated molecular patterns (DAMPs). Therefore, induction pyroptosis by small molecules promising strategy to activate antitumor immunity. In this work, we report design new class pyrazolo[1,5-a]pyrimidine-based type-I photosensitizers (PSs) as efficient inducers for cancer photodynamic therapy (PDT). Among compounds, ZS-3 exhibited most excellent reactive oxygen species (ROS) generation ability phototoxicity in vitro. It was found that induced caspase-3/gasdermin E (GSDME) pathway under light irradiation, characterized bubble formation pattern release. Furthermore, lipid nanoparticles significantly inhibited growth evoked immune responses vivo.

Язык: Английский

Процитировано

0

Advances in cancer immunotherapy: historical perspectives, current developments, and future directions DOI Creative Commons

Mei‐Yin Zhang,

Chao-jun Liu,

Jing Tu

и другие.

Molecular Cancer, Год журнала: 2025, Номер 24(1)

Опубликована: Май 7, 2025

Cancer immunotherapy, encompassing both experimental and standard-of-care therapies, has emerged as a promising approach to harnessing the immune system for tumor suppression. Experimental strategies, including novel immunotherapies preclinical models, are actively being explored, while established treatments, such checkpoint inhibitors (ICIs), widely implemented in clinical settings. This comprehensive review examines historical evolution, underlying mechanisms, diverse strategies of cancer highlighting its applications ongoing advancements. The delves into essential components anticancer immunity, dendritic cell activation, T priming, surveillance, addressing challenges posed by evasion mechanisms. Key immunotherapeutic vaccines, oncolytic viruses, adoptive transfer, ICIs, discussed detail. Additionally, role nanotechnology, cytokines, chemokines, adjuvants enhancing precision efficacy were explored. Combination particularly those integrating immunotherapy with radiotherapy or chemotherapy, exhibit synergistic potential but necessitate careful management reduce side effects. Emerging factors influencing outcomes, heterogeneity, gut microbiota composition, genomic epigenetic modifications, also examined. Furthermore, molecular mechanisms therapeutic resistance analyzed, focus on contributions noncoding RNAs alterations, along innovative intervention strategies. emphasizes recent advancements, particular attention biomarker-driven approaches aimed at optimizing patient prognosis. Challenges immunotherapy-related toxicity, limited solid tumors, production constraints highlighted critical areas future research. Advancements personalized therapies delivery systems proposed avenues enhance treatment effectiveness accessibility. By incorporating insights from multiple disciplines, this aims deepen understanding application ultimately fostering more effective accessible solutions.

Язык: Английский

Процитировано

0

Microwave‐Responsive AlEu‐MOFs Potentiate NLRP3‐Mediated Pyroptosis via a “Triple Initiating” Tactic for Breast Cancer Microwave‐Immunotherapy DOI
Qiong Wu,

Lirong Zhao,

Longfei Tan

и другие.

Small, Год журнала: 2025, Номер unknown

Опубликована: Май 9, 2025

Abstract Microwave thermotherapy is favored in clinical practice for breast cancer conservation strategies due to its minimally invasive characteristic. Nevertheless, the immunosuppressive tumor microenvironment (TME) significantly attenuates therapeutic efficacy of anti‐tumor immune response, posing challenges effectively preventing recurrence and metastasis. Pyroptosis, a recently identified form programmed cell death triggered by inflammasomes, presents unique inflammatory immunogenic properties that hold promise immunotherapy. Herein, microwave‐responsive AlEu‐MOFs are designed synthesized boost NLRP3‐mediated pyroptosis via “Triple Initiating” tactic microwave‐immunotherapy. The potent microwave thermal effect AEM facilitates up‐regulation HSP90, thereby initiating NLRP3 expression. Concurrently, it induces mitochondrial dysfunction generate substantial quantities ROS, further enhancing expression achieve targeted amplification thermotherapy‐induced pyroptosis. Simultaneously, directed anchoring release highly active metal ions promotes activation inflammasome jointly, ultimately inducing high‐efficiency This innovative “2M” (materials methods) dual‐pronged strategy not only inhibits primary proliferation, but also impedes distant progression lung work provides novel accurately offers new approach overcome obstacles thermotherapy.

Язык: Английский

Процитировано

0

Synergistic photoinduction of ferroptosis and apoptosis by a mitochondria-targeted iridium complex for bladder cancer therapy DOI Creative Commons

J Zheng,

Aijing Zhang, Qinglong Du

и другие.

Journal of Colloid and Interface Science, Год журнала: 2024, Номер 683, С. 420 - 431

Опубликована: Дек. 12, 2024

Bladder cancer (BC) is one of the most common malignant tumors urinary system, and has a high recurrence rate treatment resistance. Recent results indicate that mitochondrial metabolism influences therapeutic outcomes BC. Mitochondria-targeted photosensitizer (PS) promising anticancer approach may overcome limitations conventional BC treatments. Herein, two mitochondria-targeted iridium(III) PSs, Ir-Mito1 Ir-Mito2, have been designed for treatment. Mechanically, Ir-Mito2 induced decrease in membrane potential via white light activation, further triggering reduction B-cell lymphoma 2 protein (Bcl-2)/Bcl-associated X (Bax) ratio increment cleaved caspase3. Meanwhile, glutathione, deactivation glutathione peroxidase 4 (GPX4), increase acyl-CoA synthetase long chain family member (ACSL4), accumulation lipid peroxide resulted synergistically activating ferroptosis apoptosis. The demonstrated exhibited excellent antitumor efficacy with superior biosafety vivo. This work on light-activated mitochondrial-targeted PS provides an innovative platform

Язык: Английский

Процитировано

0